147 related articles for article (PubMed ID: 22108905)
1. DNA promoter methylation status and protein expression of interleukin-8 in human colorectal adenocarcinomas.
Dimberg J; Ström K; Löfgren S; Zar N; Lindh M; Matussek A
Int J Colorectal Dis; 2012 Jun; 27(6):709-14. PubMed ID: 22108905
[TBL] [Abstract][Full Text] [Related]
2. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.
Wang YC; Yu ZH; Liu C; Xu LZ; Yu W; Lu J; Zhu RM; Li GL; Xia XY; Wei XW; Ji HZ; Lu H; Gao Y; Gao WM; Chen LB
World J Gastroenterol; 2008 May; 14(19):3074-80. PubMed ID: 18494062
[TBL] [Abstract][Full Text] [Related]
3. Expression of BMP6 is associated with its methylation status in colorectal cancer tissue but lacks prognostic significance.
Sangplod P; Kanngurn S; Boonpipattanapong T; Ruangrat P; Sangkhathat S
Asian Pac J Cancer Prev; 2014; 15(17):7091-5. PubMed ID: 25227796
[TBL] [Abstract][Full Text] [Related]
4. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
5. Involvement of methylation-associated silencing of formin 2 in colorectal carcinogenesis.
Li DJ; Feng ZC; Li XR; Hu G
World J Gastroenterol; 2018 Nov; 24(44):5013-5024. PubMed ID: 30510376
[TBL] [Abstract][Full Text] [Related]
6. Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancer.
Øster B; Linnet L; Christensen LL; Thorsen K; Ongen H; Dermitzakis ET; Sandoval J; Moran S; Esteller M; Hansen TF; Lamy P; ; Laurberg S; Ørntoft TF; Andersen CL
Int J Cancer; 2013 May; 132(10):2303-15. PubMed ID: 23115050
[TBL] [Abstract][Full Text] [Related]
7. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
8. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis.
Semaan A; Uhl B; Branchi V; Lingohr P; Bootz F; Kristiansen G; Kalff JC; Matthaei H; Pantelis D; Dietrich D
Clin Colorectal Cancer; 2018 Jun; 17(2):e385-e393. PubMed ID: 29580650
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of plasma epigenetic changes of five major genes involved in the pathogenesis of colorectal cancer.
Pack SC; Kim HR; Lim SW; Kim HY; Ko JY; Lee KS; Hwang D; Park SI; Kang H; Park SW; Hong GY; Hwang SM; Shin MG; Lee S
Int J Colorectal Dis; 2013 Jan; 28(1):139-47. PubMed ID: 22990173
[TBL] [Abstract][Full Text] [Related]
10. Impact of MTHFR gene C677T polymorphism on Bcl-2 gene methylation and protein expression in colorectal cancer.
Zhu Q; Jin Z; Yuan Y; Lu Q; Ge D; Zong M
Scand J Gastroenterol; 2011 Apr; 46(4):436-45. PubMed ID: 21128871
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation and expression of SOCS-1 affect clinical outcome and epithelial-mesenchymal transition in colorectal cancer.
Kang XC; Chen ML; Yang F; Gao BQ; Yang QH; Zheng WW; Hao S
Biomed Pharmacother; 2016 May; 80():23-29. PubMed ID: 27133036
[TBL] [Abstract][Full Text] [Related]
12. Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue.
Suter CM; Martin DI; Ward RL
Int J Colorectal Dis; 2004 Mar; 19(2):95-101. PubMed ID: 14534800
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation inactivate tumor suppressor FAM134B and is associated with poor prognosis in colorectal cancer.
Islam F; Gopalan V; Pillai S; Lu CT; Kasem K; Lam AK
Genes Chromosomes Cancer; 2018 May; 57(5):240-251. PubMed ID: 29318692
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.
Tong JD; Jiao NL; Wang YX; Zhang YW; Han F
Neoplasma; 2011; 58(5):441-8. PubMed ID: 21744999
[TBL] [Abstract][Full Text] [Related]
15. O6-Methyguanine-DNA Methyl Transferase (MGMT) Promoter Methylation in Serum DNA of Iranian Patients with Colorectal Cancer.
Alizadeh Naini M; Kavousipour S; Hasanzarini M; Nasrollah A; Monabati A; Mokarram P
Asian Pac J Cancer Prev; 2018 May; 19(5):1223-1227. PubMed ID: 29801405
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypomethylation of RAR-related orphan receptor α 1 is correlated with unfavorable clinicopathological features in patients with colorectal cancer.
Kano H; Takayama T; Midorikawa Y; Nagase H
Biosci Trends; 2016 Jul; 10(3):202-9. PubMed ID: 27301432
[TBL] [Abstract][Full Text] [Related]
17. DNA hypomethylation at the CpG island is involved in aberrant expression of the L1 cell adhesion molecule gene in colorectal cancer.
Kato K; Maesawa C; Itabashi T; Fujisawa K; Otsuka K; Kanno S; Tada H; Tatemichi Y; Kotani K; Oikawa H; Sugai T; Wakabayashi G; Masuda T
Int J Oncol; 2009 Sep; 35(3):467-76. PubMed ID: 19639167
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of endothelin-3 in colorectal cancer.
Olender J; Nowakowska-Zajdel E; Kruszniewska-Rajs C; Orchel J; Mazurek U; Wierzgoń A; Kokot T; Muc-Wierzgoń M
Int J Immunopathol Pharmacol; 2016 Jun; 29(2):333-40. PubMed ID: 26684626
[TBL] [Abstract][Full Text] [Related]
19. Significant association of PRMT6 hypomethylation with colorectal cancer.
Pan R; Yu H; Dai J; Zhou C; Ying X; Zhong J; Zhao J; Zhang Y; Wu B; Mao Y; Wu D; Ying J; Duan S
J Clin Lab Anal; 2018 Nov; 32(9):e22590. PubMed ID: 29927001
[TBL] [Abstract][Full Text] [Related]
20. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]